Not recruitingISRCTN23246262

A comparison of the efficacy and the safety of venlafaxine versus nortriptyline in the treatment of depressed elderly inpatients

This study is not recruiting in the Netherlands. It focuses on Depressive disorders; Mental and Behavioural Disorders; Depression.

Depression, Mental healthOther

The study in practice

Understand this study

We have not yet verified a detailed participation summary for this study.

Compensation and expense reimbursement have not been verified for this summary.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Altrecht GGZ (The Netherlands)
Sponsor type: Unknown or unclear
Study type: Other
Intervention type: Other / unclear
Study phase: Not clearly listed
Locations: Netherlands
Age range: Not clearly listed
Official registry ID: ISRCTN23246262
Official title: A randomised, double-blind, parallel-group comparison of the efficacy and the safety of venlafaxine versus nortriptyline in the treatment of depressed elderly inpatients

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: ISRCTN23246262. We help you review the study, but cannot decide medical eligibility.

Not recruiting

Netherlands

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Altrecht GGZ (The Netherlands).

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.